The Israeli biopharmaceutical company will focus on developing drugs to treat schizophrenia and Alzheimer’s psychosis. | Read More in Front – Globes
Mental health treatment co Syremis Therapeutics raises $165m
Recent Posts
The Jerusalem Post
Hong Kong arrests 21 involved in building renovation on suspicion of corruption
January 2, 2026PA condemns ‘Judaization project’ after Israel takes over planning for Tomb of the Patriarchs
January 2, 2026Iran’s streets are burning, why Israel cannot look away
January 2, 2026Eight businesses employing over 50 illegal immigrants closed in police crackdown
January 2, 2026
YnetNews
Despite pressure, number of religious women enlisting in IDF doubles; first combat platoon formed for them
January 2, 2026
Trump threatens to aid Iranian protesters if regime opens fire; Tehran warns of regional chaosJanuary 2, 2026New York swears in Zohran Mamdani as mayor as Israeli critics protest nearby
January 2, 2026
First alert in months along northern border; interceptor launch identified near SafedJanuary 2, 2026
Arutz Sheva
‘Death to the dictator’: Minister Ben-Gvir’s Tweet in FarsiJanuary 2, 2026
Rescue forces save stranded family, injured rider in separate water incidentsJanuary 2, 2026
Diaspora Minister: ‘New York mayor an overt anitsemite & terror supporter’January 2, 2026
IDF strikes Hezbollah training compoundJanuary 2, 2026
JTA
- January 2, 2026
- ‘Death to the dictator’: Minister Ben-Gvir’s Tweet in FarsiJanuary 2, 2026
- January 2, 2026
‘Locked and loaded’: Trump and Iranian officials exchange threats over protests
January 2, 2026- January 2, 2026